Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells

Cancer Cell International

Volumn 10, Issue , 2010, Pages

  Griffin, Carly ^a   Hamm, Caroline ^b   McNulty, James ^c   Pandey, Siyaram ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b Centre Regional De Cancerologie De Windsor   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYMENOCALLIS LITTORALIS EXTRACT; PANCRATISTATIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG SCREENING; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYMENOCALLIS LITTORALIS; LEUKEMIA; LEUKEMIA CELL LINE; LEUKEMIA RELAPSE; MEDICINAL PLANT; MYELODYSPLASTIC SYNDROME; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL;

EID: 78751503441     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-10-6     Document Type: Article

References (11)

1. Siedlakowski P, McLachlan-Burgess A, Griffin C, Tirumalai SS, McNulty J, Pandey S. Synergy of Pancratistatin and Tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria. Cancer Biol Ther 2007, 7(3):376-384.
2. McLachlan A, Kekre N, McNulty J, Pandey S. Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis 2005, 10:619-630. 10.1007/s10495-005-1896-x, 15909123.
3. Kekre N, Griffin C, McNulty J, Pandey S. Pancratistatin causes early activation of caspase-3 and flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemother Pharmacol 2005, 56(1):29-38. 10.1007/s00280-004-0941-8, 15726366.
4. Dumont P, Ingrassia L, Rouzeau S, Ribaucour F, Thomas S, Roland I, Darro F, Lefranc F, Kiss R. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts. Neoplasia 2007, 9(9):766-76. 10.1593/neo.07535, 1993861, 17898872.
5. Gerber DE. Targeted therapies: a new generation of cancer treatments. Amer Fam Physician 2008, 77(3):311-319.
6. Sonnichsen DS, Relling MV. Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet 1994, 27(4):256-69. 10.2165/00003088-199427040-00002, 7834963.
7. Griffin C, Sharda N, Sood D, Nair J, McNulty J, Pandey S. Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds. Cancer Cell Int 2007, 7:10. 10.1186/1475-2867-7-10, 1892540, 17550595.
8. Wang J, Li L, Cang H, Shi G, Yi J. NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells. Leukemia Res 2008, 32(3):429-436.
9. Vondrácek J, Soucek K, Sheard MA, Chramostová K, Andrysík Z, Hofmanová J, Kozubík A. Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization. Leukemia Res 2006, 30(1):81-89.
10. Liu X, Jiang J, Jiao X, Wu Y, Lin J, Cai Y. Lycorine induces apoptosis and down-regulation of Mcl-1 in human leukemia cells. Cancer Lett 2009, 274(1):16-24. 10.1016/j.canlet.2008.08.029, 18829157.
11. Kornienko A, Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chemistry Reviews 2008, 108(6):1982-2014.